Ramsay Generale dente (XPAR:GDS) EBIT: €120 Mil (TTM As of Dec. 2025)


XPAR:GDS Ramsay Generale de Sante SA XPAR:GDS
71 GF Score
Price €11.30
GF Value €21.72
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Ramsay Generale dente EBIT?

Ramsay Generale dente XPAR:GDS -1.31% 71 EBIT is €120 Mil as of Dec. 2025. GuruFocus rates XPAR:GDS with a GF Score™ of 71/100 and a GF Value™ of €21.72 (Possible Value Trap). The stock has 8 warning signs investors should review.

Ramsay Generale dente's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2025 was €0 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was €120 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Ramsay Generale dente's annualized ROC % for the quarter that ended in Dec. 2025 was 0.00%. Ramsay Generale dente's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 0.00%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Ramsay Generale dente's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 2.37%.


Ramsay Generale dente  (XPAR:GDS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Ramsay Generale dente's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=0 * ( 1 - 0% )/( (6715.1 + 6489.8)/ 2 )
=0/6602.45
=0.00 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Ramsay Generale dente's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=0/( ( (2913.34 + max(-362.8, 0)) + (2882 + max(-215, 0)) )/ 2 )
=0/( ( 2913.34 + 2882 )/ 2 )
=0/2897.67
=0.00 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(527.5 + 125.1 + 267) - (437.7 + 0 + 844.7)
=-362.8

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(484.5 + 129.4 + 254.3) - (412.6 + 0 + 670.6)
=-215

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Ramsay Generale dente's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=120.4/5082.074
=2.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ramsay Generale dente EBIT Related Terms


Ramsay Generale dente EBIT Historical Data

* Premium members only.

The historical data trend for Ramsay Generale dente's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ramsay Generale dente EBIT Chart

Ramsay Generale dente Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 224.60 299.80 242.40 158.20 162.00

Ramsay Generale dente Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 51.60 55.10 0.00 65.30

XPAR:GDS vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Ramsay Generale dente's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ramsay Generale dente EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Generale dente's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ramsay Generale dente's EV-to-EBIT falls into.


XPAR:GDS
71GF Score
Ramsay Generale de Sante SA XPAR:GDS
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ramsay Generale dente EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €120 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €120 Mil mean?
Ramsay Generale dente (XPAR:GDS) has a EBIT of €120 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Ramsay Generale dente.
Is Ramsay Generale dente's EBIT too high?
Ramsay Generale dente's current EBIT is €120 Mil. Overall, Ramsay Generale dente has a GF Score™ of 71/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ramsay Generale dente's EBIT compare to HCA and THC?
Ramsay Generale dente's EBIT of €120 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Ramsay Generale dente. Ramsay Generale dente's current EBIT is €120 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Generale dente stock overvalued right now?
Based on GuruFocus' analysis, Ramsay Generale dente (XPAR:GDS) is currently considered Possible Value Trap. The stock's GF Value™ is €21.72, compared to a current price of €11.30 — trading 48% below its estimated fair value. The current EBIT is €120 Mil. Ramsay Generale dente's overall GF Score™ is 71/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Ramsay Generale dente (XPAR:GDS), the current EBIT is €120 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ramsay Generale dente (XPAR:GDS) Overvalued in 2026?

Based on GuruFocus' analysis, Ramsay Generale dente stock appears to be undervalued. The current stock price of €11.30 is trading 48% below its estimated GF Value™ of €21.72. GuruFocus considers Ramsay Generale dente to be Possible Value Trap.

Key valuation signals for XPAR:GDS:

  • EBIT: €120 Mil
  • GF Value™: €21.72 vs. price of €11.30 (48% below fair value)
  • GF Score™: 71/100 with 8 warning signs

No single metric tells the full story. See the XPAR:GDS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ramsay Generale dente Business Description

Other Exchanges 0OD6:UKGD6:Germany
Address 39 Rue Mstislav, Rostropovitch, Paris, FRA, 75017
Ramsay Generale de Sante SA operates in the private healthcare sector in France. The company provides a comprehensive range of patient care services in thirteen business segments: Nouvelle Aquitaine, Bourgogne-Franche Comte, Brittany, Centre-Val de Loire, Hauts de France, Normandy, Provence Alpes Cote d'Azur, Ile de France, Auvergne-Rhone Alpes, Occitanie, Italy, Nordics, and Head Office. It generates maximum revenue from the Ile de France segment. The company also specializes in cardiology, heart surgery, digestive surgery, dermatology, urology, ophthalmology, vascular and endovascular surgery.
71GF Score

Get the complete analysis for XPAR:GDS

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.30
Price
€21.72
GF Value